Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 7589510)

Published in FEBS Lett on October 23, 1995

Authors

Y Ezumi1, H Takayama, M Okuma

Author Affiliations

1: Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.

Articles citing this

Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet (2006) 3.26

Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A (1998) 1.97

Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med (1998) 1.89

Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells (2009) 1.52

Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci U S A (1997) 1.39

Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity. Circulation (2012) 0.96

Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles. Front Immunol (2015) 0.84

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med (2013) 0.84

Congenital amegakaryocytic thrombocytopenia: a brief review of the literature. Clin Med Insights Pathol (2010) 0.82

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation. Blood (2014) 0.81

Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression. Leukemia (2012) 0.81

Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag. Saudi J Gastroenterol (2010) 0.81

Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels. Front Endocrinol (Lausanne) (2011) 0.79

Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm (2012) 0.78

Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy. J Hematol Oncol (2015) 0.78

Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia. Core Evid (2006) 0.76

Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome. Haematologica (2011) 0.76

The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin. Front Endocrinol (Lausanne) (2017) 0.75

Articles by these authors

Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 2.93

Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58

Neonatal sunburn and melanoma in mice. Nature (2001) 2.25

Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med (1998) 1.89

A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest (1989) 1.82

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem (2000) 1.65

Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage (2006) 1.64

Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett (1997) 1.62

Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol (1994) 1.62

A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem (1997) 1.61

Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti-platelet antibodies. Vox Sang (1991) 1.60

Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood (1998) 1.59

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (1997) 1.58

Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem (1999) 1.57

c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54

Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res (1999) 1.50

Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop Relat Res (2001) 1.41

Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes. J Exp Med (1987) 1.39

Non-Hodgkin's lymphoma involving bilateral breasts. Intern Med (1998) 1.38

Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature (1987) 1.37

Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36

Activity and toxicity of bleomycin. J Antibiot (Tokyo) (1967) 1.35

Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem (1997) 1.35

A mesenteric liposarcoma with production of granulocyte colony-stimulating factor. Intern Med (1998) 1.34

Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both alpha2beta1 integrin and GP VI. J Biol Chem (1999) 1.29

Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur J Pharmacol (1996) 1.29

Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species. Br J Pharmacol (1986) 1.25

Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. J Exp Med (1992) 1.24

Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8. Oncogene (1997) 1.23

Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest (1994) 1.23

Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J Clin Invest (1975) 1.21

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J Natl Cancer Inst (2001) 1.21

A New Indole Alkaloid, 7 alpha-Hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med (1994) 1.20

A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood (1987) 1.17

Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest (1996) 1.13

TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids. FEBS Lett (1986) 1.13

Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1. J Biol Chem (1997) 1.13

Endoscopic aspiration mucosectomy as curative endoscopic surgery; analysis of 24 cases of early gastric cancer. Gastrointest Endosc (1995) 1.13

Studies on lipid peroxides in platelets. I. Method of assay and effect of storage. J Lab Clin Med (1970) 1.12

Antigen receptor-triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes. J Immunol (1987) 1.12

Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer (2007) 1.09

Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem (1995) 1.07

Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol (1998) 1.07

Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. J Biol Chem (1997) 1.06

Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer (1998) 1.06

Differential expression of calmodulin-binding proteins in B, T lymphocytes and thymocytes. Nature (1987) 1.04

Twin-stage procedure. Part 1: A new method to reproduce precise eccentric occlusal relations. Int J Periodontics Restorative Dent (1997) 1.04

Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity. J Immunol (1994) 1.04

Scanning electron microscopy detects bacteria within infection stones. J Urol (1984) 1.03

Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. J Biol Chem (1977) 1.02

Iron enhances hepatitis C virus replication in cultured human hepatocytes. Liver (2000) 1.02

Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. Am J Hematol (1992) 1.02

Endoscopic aspiration lumpectomy of esophageal leiomyomas derived from the muscularis mucosae. Am J Gastroenterol (1995) 1.02

Coding sequence of human placenta cofilin cDNA. Nucleic Acids Res (1990) 1.02

Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets. J Biol Chem (1989) 1.01

Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene (1993) 1.01

Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Life Sci (1996) 1.01

Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody. J Lab Clin Med (1971) 1.00

Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes. J Immunol (1987) 1.00

Differential regulation of protein-tyrosine phosphatases by integrin alpha IIb beta 3 through cytoskeletal reorganization and tyrosine phosphorylation in human platelets. J Biol Chem (1995) 1.00

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat (2001) 0.99

A conserved epitope on H+,K(+)-adenosine triphosphatase of parietal cells discerned by a murine gastritogenic T-cell clone. Gastroenterology (1994) 0.98

Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. J Med Chem (2000) 0.98

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Gut (2002) 0.98

Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sci (1998) 0.98

Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development. Pigment Cell Res (1999) 0.98

Isolation and bioactivities of constitutents of the roots of Garcinia atroviridis. J Nat Prod (2001) 0.98

Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett (2001) 0.96

Twin-Stage Procedure. Part 2: A clinical evaluation test. Int J Periodontics Restorative Dent (1997) 0.96

B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes. J Immunol (1988) 0.95

Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem (1998) 0.95

Dinoflagellate Alexandrium tamarense as the source of paralytic shellfish poison (PSP) contained in bivalves from Hiroshima Bay, Hiroshima Prefecture, Japan. Toxicon (1995) 0.95

Effect of canine guidance on the working condylar path. Int J Prosthodont (1990) 0.95

Sensitivity of volume-sensitive Cl- conductance in human epithelial cells to extracellular nucleotides. Am J Physiol (1996) 0.95

Stereochemistry of 25-hydroxyvitamin D3-26,23-lactone and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in rat serum. FEBS Lett (1981) 0.94

Endoscopic resection of gastrointestinal submucosal lesions: a comparison between strip biopsy and aspiration lumpectomy. Gastrointest Endosc (1996) 0.94

Expression of alpha-(1,3)-fucosyltransferases which synthesize sialyl Le(x) and sialyl Le(a), the carbohydrate ligands for E- and P-selectins,in human malignant cell lines. Cancer Res (1993) 0.94

The IL-2 receptor alpha-chain alters the binding of IL-2 to the beta-chain. J Immunol (1991) 0.93

Vascular complications in living related liver transplantation detected with intraoperative and postoperative Doppler US. J Hepatol (1995) 0.93

Hepatic hydrothorax in the absence of ascites. Liver (1998) 0.93

Transcatheter hepatic arterial drug infusion therapy for hepatocellular carcinoma. Effect on the arterial ketone body ratio. Scand J Gastroenterol (1993) 0.92

Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy. Endoscopy (1997) 0.92

A case of postganglionic cholinergic dysautonomia. J Neurol Neurosurg Psychiatry (1987) 0.92

A model of in vivo cell proliferation of adult T-cell leukemia. Blood (1993) 0.92

Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene (1999) 0.92

Effects of mitragynine on cAMP formation mediated by delta-opiate receptors in NG108-15 cells. Biol Pharm Bull (1997) 0.91

Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. Gen Pharmacol (1999) 0.91

Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Cancer Res (1993) 0.91

Hepatocellular carcinoma with pleural metastasis complicated by hemothorax. Am J Gastroenterol (1996) 0.91

Antigen-receptor interaction requirement for conjugate formation and lethal-hit triggering by cytotoxic T lymphocytes can be bypassed by protein kinase C activators and Ca2+ ionophores. Proc Natl Acad Sci U S A (1987) 0.90

Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. Keio J Med (1987) 0.90

Efficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptors. J Org Chem (2001) 0.90

Modification of human immunodeficiency viral replication by pine cone extracts. AIDS Res Hum Retroviruses (1990) 0.90

Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI. Biochem Biophys Res Commun (2000) 0.90

Inactivation and proteolytic degradation of perforin within lytic granules upon neutralization of acidic pH. Immunology (1997) 0.89

Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo. Blood (1995) 0.89

Cell death-associated translocation of plasma membrane components induced by CTL. J Immunol (2000) 0.89